Hamblin, M.R. - Transcranial Photobiomodulation for Brain Disorders: A Literature Review

This 2016 publication is a literature review, not a clinical trial. It describes the proposed mechanisms of transcranial photobiomodulation and reviews the preclinical studies and clinical trials conducted on various brain disorders.

What This Publication Covers

Photobiomodulation refers to the use of red or near-infrared light to stimulate, repair, regenerate, and protect tissue that is damaged, degenerating, or at risk. The author, affiliated with the Wellman Center for Photomedicine at Massachusetts General Hospital, applies this definition to the brain and provides an overview of the field.

This is a review article, indexed as such in PubMed. It contains no meta-analysis, no systematic review described in the abstract, and no aggregated figures. Brain disorders are classified into three groups: traumatic events, which include stroke, head trauma, and global ischemia; degenerative diseases, including dementia, Alzheimer’s disease, and Parkinson’s disease; and psychiatric disorders, including depression, anxiety, and post-traumatic stress disorder.

The reported items

The summary does not contain any numerical data. Here are the qualitative findings presented by the author.

• According to the journal, there are “some indications” that these very diverse conditions may be positively influenced by applying light to the head.
• The author discusses the possibility of using cognitive enhancement in healthy individuals, presenting it as a possibility rather than an established fact.
• In transcranial applications, near-infrared light is often directed at the forehead because of its greater penetration: the absence of hair and a higher wavelength.
• Some teams used lasers; the advent of inexpensive light-emitting diode arrays made it possible to develop light-emitting helmets.
• No population, no specified wavelength, and no dose are listed in the summary.

How photobiomodulation works for this indication

The journal states that it covers the mechanisms of action of photobiomodulation as applied to the brain, though it does not elaborate on them in its abstract. The principle generally put forward in this field remains hypothetical: red and near-infrared light is said to be absorbed by mitochondrial chromophores, which would alter cellular energy metabolism. The specific issue regarding the brain is that of penetration through the scalp and bone, which the author links to the choice of the forehead as the application site and to the use of longer wavelengths.

Limits You Should Know

The main limitation is the type of publication. A narrative review selects and discusses studies; it does not measure anything and does not allow for any estimation of effect. The cautious wording used by the author—particularly the reference to “some evidence”—should be interpreted as such.

Grouping conditions as diverse as stroke, Alzheimer’s disease, and depression under a single technological umbrella does not mean that the level of evidence is comparable across these indications. With regard to neurodegenerative diseases in particular, nothing in this text supports the claim that the technology has any effect on the course of the disease. Finally, this review dates from 2016: subsequent trials and meta-analyses exist—including those with negative results—and should be consulted to obtain an up-to-date understanding.

What This Means in Practice

This text serves as an introduction to the field and a classification framework, not as evidence of efficacy. It does not provide a basis for recommending transcranial photobiomodulation for any of the indicated conditions. The parameters for use—wavelength, power, duration, and number of sessions—are not specified in the abstract. Any questions regarding a neurological or psychiatric disorder should be addressed through medical care.

Frequently Asked Questions

Does this study prove that light heals the brain?

No. This is a literature review, a format that compiles and discusses existing research without producing its own findings. The author states that there is “some evidence” supporting an effect, which is a cautious statement rather than a proof.

Why is the light applied to the forehead?

Because penetration is better there, for two reasons cited by the author: the absence of hair and the use of a longer wavelength in the near-infrared range. The abstract does not provide any specific figures regarding the depth achieved.

Is a light-up helmet as good as a laser device?

The journal does not compare the two. It merely states that lasers were used first, and that inexpensive light-emitting diode arrays later made light-emitting helmets possible. It does not establish that one is superior to the other.

Reference

Hamblin, M.R. “Shining light on the head: Photobiomodulation for brain disorders.” BBA Clinical, 2016. PMID 27752476. View the study on PubMed

This summary is provided for informational purposes only and does not constitute medical advice. Photobiomodulation is not a substitute for prescribed treatment. Consult a healthcare professional.